Disclosures for "High-dose cyclophosphamide as a rescue treatment for fulminant Marburg multiple sclerosis: A case report")
-
Dr. Roberts has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Abdullah has nothing to disclose.
-
Miss Shoga has nothing to disclose.
-
Dr. Reyna has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Reyna has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Reyna has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Reyna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Reyna has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. Reyna has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Reyna has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Reyna has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Reyna has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Reyna has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Serono. Dr. Reyna has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Reyna has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
-
An immediate family member of Dr. Parker has received personal compensation for serving as an employee of Rochal Industries, Rochal Parners. An immediate family member of Dr. Parker has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sanara Med Tech. An immediate family member of Dr. Parker has stock in Sanara Med Tech. An immediate family member of Dr. Parker has stock in Rochal Industries. An immediate family member of Dr. Parker has stock in Rochal Parnters. The institution of Dr. Parker has received research support from Texas Alzheimer's Research and Care Consortium. The institution of an immediate family member of Dr. Parker has received research support from Rochal Industries. An immediate family member of Dr. Parker has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Parker has received publishing royalties from a publication relating to health care. Dr. Parker has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Speaker with Univ of Texas Tyler. An immediate family member of Dr. Parker has received personal compensation in the range of $0-$499 for serving as a NIH Review Committees Member with NIH. An immediate family member of Dr. Parker has a non-compensated relationship as a Chairwoman of the Board - Ann Salamone with BioMed SA that is relevant to AAN interests or activities.